Icahn School of Medicine
Prostate Cancer Polygenic Score Does Not Improve High-Grade Disease Prediction Over Clinical Factors
Researchers found that adding genetic risk score data did not improve their ability to predict aggressive prostate cancer cases over conventional risk stratification approaches.
Long COVID Clues Found in Acute SARS-CoV-2 Infection Blood Samples
With RNA sequencing of acute infection samples from hospitalized COVID-19 patients, researchers narrowed in on expression patterns linked to disease sequalae.
Neuropsychiatric Disease Clues Drawn From Enhancer Expression Analysis
Researchers investigated the variation in enhancer expression within a population, using the clues to better understand the risk of neuropsychiatric conditions such as schizophrenia.
BioMark Diagnostics, Icahn Mount Sinai to Develop Multiomic Lung Cancer Tests
The partners also aim to develop a test for determining lung cancer subtype and stage using circulating tumor cells and metabolomics.
Multiple Myeloma Patient Similarity Network Reveals Prognostically Informative Subgroups
Researchers identified 12 multiple myeloma subgroups based on mutation, copy number, chromosomal rearrangement, and expression features in more than 650 tumors.